Resvita Biosciences


Brief Description

Resvita Biosciences seeks to restore and maintain the vitality of the skin by properly considering the skin microbiome as part of the human body. A harmless skin probiotic will continuously deliver the therapy that a body would to maintain skin health. 

Through synthetic biology and metabolic engineering, the company's goal is to develop a safe and versatile skin microbial platform that can address the causes of skin aging and disease. Resvita Biosciences has a unique patented approach, a rich product pipeline, clear regulatory advantages, and an experienced scientific management team. 

The company is developing multiple anti-aging products, an investigational drug to treat an orphan skin disease, and treatments for inflammatory skin diseases like eczema and psoriasis.


Jay Keasling, Amin Zargar